GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Cyclically Adjusted Book per Share

Carna Biosciences (TSE:4572) Cyclically Adjusted Book per Share : 円238.07 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Carna Biosciences's adjusted book value per share for the three months ended in Mar. 2024 was 円205.192. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円238.07 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Carna Biosciences's average Cyclically Adjusted Book Growth Rate was 4.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Carna Biosciences was 7.40% per year. The lowest was 1.30% per year. And the median was 6.40% per year.

As of today (2024-06-20), Carna Biosciences's current stock price is 円378.00. Carna Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円238.07. Carna Biosciences's Cyclically Adjusted PB Ratio of today is 1.59.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Carna Biosciences was 15.34. The lowest was 1.63. And the median was 5.33.


Carna Biosciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for Carna Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Cyclically Adjusted Book per Share Chart

Carna Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 186.49 191.45 200.48 224.59 237.18

Carna Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 228.36 232.68 235.60 237.18 238.07

Competitive Comparison of Carna Biosciences's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Carna Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carna Biosciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's Cyclically Adjusted PB Ratio falls into.



Carna Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Carna Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=205.192/107.2000*107.2000
=205.192

Current CPI (Mar. 2024) = 107.2000.

Carna Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 167.616 98.000 183.351
201409 156.829 98.500 170.681
201412 99.810 97.900 109.291
201503 113.081 97.900 123.823
201506 241.079 98.400 262.639
201509 220.409 98.500 239.877
201512 210.341 98.100 229.853
201603 216.437 97.900 236.997
201606 214.844 98.100 234.773
201609 199.376 98.000 218.093
201612 188.259 98.400 205.095
201703 180.653 98.100 197.411
201706 160.048 98.500 174.184
201709 167.764 98.800 182.027
201712 144.265 99.400 155.586
201803 123.532 99.200 133.494
201806 102.292 99.200 110.541
201809 72.068 99.900 77.334
201812 87.542 99.700 94.127
201903 82.034 99.700 88.205
201906 258.339 99.800 277.494
201909 309.202 100.100 331.133
201912 330.791 100.500 352.844
202003 374.721 100.300 400.499
202006 366.347 99.900 393.117
202009 345.897 99.900 371.173
202012 308.338 99.300 332.868
202103 286.275 99.900 307.194
202106 249.097 99.500 268.374
202109 265.247 100.100 284.061
202112 324.277 100.100 347.278
202203 336.146 101.100 356.428
202206 323.932 101.800 341.115
202209 288.605 103.100 300.082
202212 256.266 104.100 263.897
202303 258.907 104.400 265.851
202306 240.529 105.200 245.102
202309 222.611 106.200 224.707
202312 226.164 106.800 227.011
202403 205.192 107.200 205.192

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Carna Biosciences  (TSE:4572) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Carna Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=378.00/238.07
=1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Carna Biosciences was 15.34. The lowest was 1.63. And the median was 5.33.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Carna Biosciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Carna Biosciences (TSE:4572) Business Description

Industry
Traded in Other Exchanges
N/A
Address
BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences (TSE:4572) Headlines

No Headlines